Nvt Gmbh
Clinical trials sponsored by Nvt Gmbh, explained in plain language.
-
New heart valve procedure shows promise for High-Risk patients
Disease control OngoingThis study looks at how well the ALLEGRA TAVI system works in real-world patients with severe, hardened aortic heart valves who are too high-risk for open-heart surgery. Researchers tracked 346 patients to see if the procedure helps them live longer and feel better. The goal is t…
Sponsor: NVT GmbH • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
New heart valve device under study for severe aortic stenosis
Disease control TerminatedThis study tests a new device called the ALLEGRA Plus THV System for people with severe aortic stenosis (a narrowed heart valve) or a failed surgical valve. About 177 participants will receive the device to see if it is safe and works well. The main goals are to check survival an…
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated May 20, 2026 11:56 UTC